Clinical characteristics of new‐onset diabetes after liver transplantation and outcomes
Open Access
- 19 January 2024
- journal article
- research article
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 8 (3) , 383-393
Abstract
Background: We aimed to identify the characteristics of new‐onset diabetes after liver transplantation (LT) (NODAT) and investigate its impacts on post‐transplant outcomes.Methods: Adult LT patients between 2014 and 2020 who used tacrolimus as initial immunosuppression and survived 3 months at least were evaluated. Patients who developed NODAT within 3 months after LT were classified as NODAT group. Also, patients were further classified as history of diabetes before LT (PHDBT) and non‐diabetes (ND) groups. Patient characteristics, post‐LT outcomes, and cardiovascular and/or pulmonary complications were compared.Results: A total of 83, 225, and 263 patients were classified into NODAT, PHDBT, and ND groups. The proportion of cholestatic liver disease and rejection within 90 days were higher in NODAT group. Mean serum tacrolimus concentration trough level in the first week after LT was 7.12, 6.12, and 6.12 ng/mL (p < 0.001). Duration of corticosteroids was significantly longer in NODAT compared to PHDBD or ND (416, 289, and 228 days, p < 0.001). Three‐year graft and patient survival were significantly worse in NODAT than ND (80.5% vs. 95.0%, p < 0.001: 82.0% vs. 95.4%, p < 0.001) but similar to PHDBT. Adjusted risks of 3‐year graft loss and patient death using Cox regression analysis were significantly higher in NODAT compared to ND (adjusted hazard ratio [aHR] 3.41, p = 0.004; aHR 3.61, p = 0.004). Incidence rates of cardiovascular or pulmonary complications after LT in NODAT were significantly higher than ND but similar to PHDBT.Conclusion: Higher initial tacrolimus concentration and early rejection might be risk factors for NODAT. NODAT was associated with worse post‐transplant outcomes.Keywords
This publication has 32 references indexed in Scilit:
- Hypomagnesemia and the risk of new-onset diabetes after liver transplantationLiver Transplantation, 2010
- Risk Factors for New-Onset Diabetes Mellitus in Adult Liver Transplant Recipients, an Analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing DatabaseTransplantation, 2010
- Diabetes Mellitus Increases the Risk of Mortality Following Liver Transplantation Independent of MELD ScoreDigestive Diseases and Sciences, 2010
- Predictive Factors for Posttransplant Diabetes Mellitus Within One-Year of Liver TransplantationTransplantation, 2008
- Steroid Avoidance in Liver Transplantation: Meta-Analysis and Meta-Regression of Randomized TrialsLiver Transplantation, 2008
- Negative Impact of New-Onset Diabetes Mellitus on Patient and Graft Survival After Liver Transplantation: Long-Term Follow UpTransplantation, 2006
- Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis c infection : An observational multicenter studyLiver Transplantation, 2006
- New-Onset Diabetes After Liver Transplantation: From Pathogenesis to ManagementLiver Transplantation, 2005
- New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta-AnalysisAmerican Journal of Transplantation, 2004
- Risk for posttransplant diabetes mellitus with current immunosuppressive medicationsAmerican Journal of Kidney Diseases, 1999